• 

  DRDO develops Covid-19 antibody detection kit 'DIPCOVAN'

  India | May 21, 2021 17:54 IST

  The DIPCOVAN kit can detect both spike as well as nucleocapsid (S&N) proteins of SARS-CoV-2 virus with a high sensitivity of 97% and specificity of 99%.

• 

  DRDO's 2G drug a 'repurposed' medicine, not new: ICMR

  India | May 20, 2021 17:53 IST

  India's first indigenous anti-COVID drug 2-DG is a "repurposed" medicine, the Indian Council of Medical Research said on Thursday. According to ICMR DG Dr. Balram Bhargava, the drug was earlier used for cancer treatment.

• 

  Dr Reddy's releases important information regarding anti-Covid drug 2DG

  India | May 19, 2021 22:34 IST

  Dr Reddy's on Wednesday released important information regarding drug 2-deoxy-D-glucose (2DG), developed by INMAS, a DRDO lab in collaboration with Dr. Reddy’s Laboratories.

• 

  Haryana to purchase DRDO's anti-COVID drug for treating coronavirus patients: Anil Vij

  India | May 18, 2021 8:05 IST

  Haryana on Monday reported 114 COVID deaths and 7,488 fresh cases, taking the state’s fatality count to 6,799 and the total infection number to 7,01,915, according to a Health Department bulletin. 

• 

  COVID India Updates: Bleeding, clotting events following vaccination 'minuscule' in India

  Health | May 17, 2021 23:22 IST

  The first batch of 2-deoxy-D-glucose (2-DG) drug developed by the Defence Research and Development Organisation (DRDO) for treatment of Covid-19 was released by Defence Minister Rajnath Singh on Monday. The medicine is being touted as a game-changer in the fight against COVID.

• 

  Rajnath Singh to release first batch of DRDO's drug 2-DG for Covid treatment

  News | May 17, 2021 11:20 IST

  The first batch of drug 2-deoxy-D-glucose drug to treat Covid-19 patients will be launched today. The drug has been developed by the Defence Research and Development Organisation (DRDO) in collaboration with Dr Reddy's Laboratories (DRL).

• 

  DRDO's 2-DG drug for treating Covid patients launched; to reduce dependence on oxygen

  India | May 17, 2021 11:51 IST

  The 2-DG (2-deoxy-D-glucose) is an anti-COVID-19 therapeutic application of the drug. It has been developed by DRDO and Dr Reddy's Laboratories.

• 

  DRDO imports zeolite to make oxygen for COVID-hit

  India | May 16, 2021 23:42 IST

  "The two aircraft carrying zeolite from Rome arrived as the first consignment of the key component," a DRDO official told IANS.

• 

  DRDO's anti-COVID drug 2-DG's first batch to be released today

  India | May 17, 2021 0:02 IST

  The first batch of anti-COVID drug 2-DG, developed by the DRDO, will be released on Monday (May 17) by Defence Minister Rajnath Singh and Health Minister Harsh Vardhan, officials said.

• 

  First batch of 10,000 doses of DRDO's 2DG Covid drug to launch next week

  India | May 14, 2021 23:48 IST

  At a time when country battles with the second wave of coronavirus, the first batch of 10,000 doses of 2DG medicine for curing COVID-19 patients would be launched early next week and will be given to patients, DRDO officials informed on Friday.

• 

  DRDO developed 2-DG drug could be game-changer in fight against Covid, says Minister

  India | May 14, 2021 18:45 IST

  The 2-DG drug developed by the Defence Research and Development Organisation (DRDO) could be a game-changer in the fight against COVID, Karnataka Health Minister Dr K Sudhakar said on Friday.

Advertisement
• 

  DRDO apprentice recruitment 2021: Application process ends on May 17 for 79 vacancies

  Jobs | May 14, 2021 16:05 IST

  The recruitment drive is being conducted for 79 vacancies. The candidates can apply through the website- drdo.gov.in

• 

  Govt approves procurement of 1.5 lakh units of DRDO's Oxycare system

  India | May 12, 2021 16:59 IST

  The government on Wednesday approved the procurement of 1,50,000 units of 'Oxycare' system developed by the Defence Research and Development Organisation (DRDO) to help in the treatment of COVID-19 patients.

• 

  DRDO's makeshift COVID-19 hospital with 250 ICU beds at BHU is operational from today

  News | May 10, 2021 19:20 IST

  In view of the increasing requirements of facilities for critical COVID-19 patients, the Defence Research and Development Organisation's makeshift COVID hospital with 250 ICU beds is operational from May 10.

• 

  Jeetega India: What is ATMAN artificial intelligence tool? Dr G Satheesh Reddy Explains

  News | May 09, 2021 11:48 IST

  DRDO has developed an Artificial Intelligence algorithm that can detect the presence of COVID-19 disease in Chest X-rays. Named ATMAN AI, the tool was developed by DRDO's Centre for Artificial Intelligence and Robotics (CAIR), with the support of 5C Network & HCG Academics.

• 

  EXCLUSIVE: DRDO's anti-Covid oral drug to roll out by May 11

  Good News | May 09, 2021 15:17 IST

  Based on these results, the DCGI's Central Drugs Standard Control Organisation (CDSCO) permitted Phase-II clinical trial of 2-DG in COVID-19 patients in May 2020. The ministry said the DRDO, along with DRL started the clinical trials to test the safety and efficacy of the drug in COVID-19 patients.

• 

  Anti-COVID 2-DG drug gets approval from DCGI for emergency use

  News | May 09, 2021 10:20 IST

  The Drugs Controller General of India has approved an anti-COVID oral drug, developed by DRDO, for emergency use as adjunct therapy in moderate to severe coronavirus patients, the defence ministry said on Saturday. It said clinical trials of the drug 2-deoxy-D-glucose (2-DG) showed that it helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence.

• 

  DCGI approves DRDO's anti-COVID drug helpful in faster recovery

  Hakikat Kya Hai | May 08, 2021 21:40 IST

  Drugs Controller General of India (DCGI) on May 08 approved emergency use DRDO's anti-COVID drug which the agency said will be helpful in faster recovery of hospitalised patients. While speaking to ANI, Institute of Nuclear Medicine and Allied Sciences (INMAS-DRDO) scientists spoken about drug 2-deoxy-D-glucose (2-DG). The drug will be of immense benefit to the people suffering from COVID-19.

• 

  How effective is DRDO's new Covid drug 2-DG? Experts Explain

  News | May 08, 2021 20:21 IST

  The drug has been developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), a leading laboratory of Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddy's Laboratories in Hyderabad.

• 

  Ground Report: DCGI gives emergency approval to DRDO-developed anti-Covid drug

  News | May 08, 2021 17:45 IST

  The Drugs Controller General of India has approved an anti-COVID oral drug, developed by DRDO, for emergency use as adjunct therapy in moderate to severe coronavirus patients, the defence ministry said on Saturday. It said clinical trials of the drug 2-deoxy-D-glucose (2-DG) showed that it helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence.